HIM
AGN

Hillsdale Investment Management’s Allergan plc AGN Stock Holding History

Hillsdale Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,995
Closed -$505K – 693
2019
Q3 		$505K Hold
2,995
– – 0.04% 344
2019
Q2 		$502K Hold
2,995
– – 0.05% 341
2019
Q1 		$439K Buy
2,995
+200
+7% +$29K 0.04% 347
2018
Q4 		$373K Buy
+2,795
New +$458K 0.04% 338
2015
Q2 		– Sell
-318
Closed -$95K – 574
2015
Q1 		$95K Buy
318
+18
+6% +$5.13K 0.02% 408
2014
Q4 		$77K Hold
300
– – 0.02% 426
2014
Q3 		$72K Hold
300
– – 0.02% 416
2014
Q2 		$67K Buy
+300
New +$62.1K 0.02% 428

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Hillsdale Investment Management's AGN Position: Q4 2019 in Review

Hillsdale Investment Management sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 2,995 shares — an estimated $505K sold.

Hillsdale Investment Management first reported a position in AGN in Q2 2014 and held it in 8 quarters. The position peaked at $505K in Q3 2019. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

  • Hillsdale Investment Management reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
  • Hillsdale Investment Management sold 2,995 Allergan plc shares in Q4 2019, an estimated $505K.
  • Hillsdale Investment Management first reported a position in Allergan plc in Q2 2014 and held it in 8 quarters.
  • Hillsdale Investment Management's Allergan plc position peaked at $505K in Q3 2019.
  • 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on Hillsdale Investment Management's 13F filing for Q4 2019, filed 12 Feb 2020.